Looks like 'shrooms might become a swanky and healthy thing to do! The fungi is affectionately called the Maitake mushroom, and literally means "dancing mushroom. Research has found it lowers blood pressure, abdominal obesity, and lipids in the blood.
Maitake Products plans to target the maitake (grifola frondosa) mushroom to treat metabolic syndrome. Metabolic syndrome is a common precondition for both coronary disease and type 2 diabetes. The condition is characterized by a group of metabolic risk factors including: abdominal obesity, atherogenic dyslipidemia, high blood pressure and insulin resistance. With the growing number of people affected by these conditions, Maitake claims there is significant market potential for its drug, SX-Fraction.
A preliminary clinical study was conducted among 19 patients with type 2 diabetes. Patients taking 9 tablets of SX-Fraction (per day) for 2 months found that it significantly reduced fasting blood glucose, triglycerides, and body weight. The possibility of maitake mushroom as a safe, natural agent for treatment of type 2 diabetes, Syndrome X and insulin resistance has been examined for the past several years and will soon prove to be a therapeutic dancing mushroom in days to come. Yeah man.Read | Permalink | Email this | Linking Blogs | Comments